![](https://endpts.com/wp-content/uploads/2024/05/Kevin-Parker-Cartography-Biosciences-CEO.jpg)
Kevin Parker, Cartography Biosciences CEO
Gilead forms pact with Cartography to map new targets for cancer drugs
Gilead will work with fellow California biotech Cartography Biosciences to find new targets for breast and lung cancer medicines, the companies said Tuesday morning. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.